Plasma renin activity-guided strategy for the management of hypertension.

Item

http://www.wikidata.org/entity/Q38001331

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Plasma renin activity-guided strategy for the management of hypertension.

@en

type

Item

label

Plasma renin activity-guided strategy for the management of hypertension.

@en

prefLabel

Plasma renin activity-guided strategy for the management of hypertension.

@en

P1476

Plasma renin activity-guided strategy for the management of hypertension.

@en

P2093

Augustus Hough

http://www.w3.org/2001/XMLSchema#string

Beth DeJongh

http://www.w3.org/2001/XMLSchema#string

David Parra

http://www.w3.org/2001/XMLSchema#string

Nicole Olson

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness.

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations.

The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.

Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.

Using plasma renin (PRA) testing to design follow-up drug treatment strategies in hypertensive patients already taking antirenin system drugs.

P304

446-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1875-9114.2012.01031.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22488371

http://www.w3.org/2001/XMLSchema#string